Outcome of elderly DLBCL patients with 6xCHOP-14 and 8 rituximab (R) applications given over an extended period (SMARTE-R-CHOP-14 trial of the DSHNHL).
Niels Murawski
No relevant relationships to disclose
Gerhard Held
No relevant relationships to disclose
Samira Zeynalova
No relevant relationships to disclose
Carsten Mueller
No relevant relationships to disclose
Viola Poeschel
Other Remuneration - Roche
Andreas Viardot
Honoraria - Roche
Mathias Haenel
No relevant relationships to disclose
Ulrich Keller
Consultant or Advisory Role - Roche
Honoraria - Roche
Marcel Reiser
No relevant relationships to disclose
Marita Ziepert
No relevant relationships to disclose
Norbert Schmitz
Consultant or Advisory Role - Roche
Honoraria - Roche
Research Funding - Roche
Michael Pfreundschuh
Consultant or Advisory Role - Amgen; Merck; Onyx; Pfizer; Roche